Northwestern Mutual Wealth Management CO Clovis Oncology, Inc. Transaction History

Northwestern Mutual Wealth Management CO

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 04, 2022	SELL	$0.63 - $2.96 $1,260 - $5,920	-2,000 Reduced 81.97%	440 $1,000
Q1 2022 May 09, 2022	BUY	$1.43 - $3.14 $2,772 - $6,088	1,939 Added 387.03%	2,440 $5,000
Q4 2021 Feb 03, 2022	BUY	$2.7 - $4.76 $1,217 - $2,146	451 Added 902.0%	501 $1,000
Q3 2021 Nov 15, 2021	BUY	$4.06 - $5.8 $202 - $290	50 New	50 $0
Q4 2019 Feb 13, 2020	SELL	$3.0 - $16.43 $450 - $2,464	-150 Closed	0 $0
Q3 2019 Nov 12, 2019	BUY	$3.93 - $15.35 $589 - $2,302	150 New	150 $1,000

166

Ticker CLVS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 144,480,000
Market Cap $13M
Description
Clovis Oncology, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing anti-cancer agents in the United States, Europe, and internationally. In the U.S., the company offers Rubraca (rucaparib), an oral small molecule inhibitor of poly ADP-ribose polymerase for recurrent epithelial ovarian, fallopian tube, or pr...

Get notified when there are updates to the investment portfolio of Northwestern Mutual Wealth Management CO, based on Form 13F filings with the SEC.

Stay updated on Northwestern Mutual Wealth Management CO with notifications on news.